CROHN’S DISEASE PATIENTS WITH USTEKINUMAB-INDUCED REMISSION ARE CHARACTERIZED BY HIGH BASELINE IL23 RECEPTOR EXPRESSION IN THE LAMINA PROPRIA TH1 CELLS

Sara Onali  1     Amalia Di Petrillo  1     Claudia Carpineti  1     Marta Cadoni  1     Erica Loddo  1     Massimo Claudio Fantini  1    
1 University of Cagliari, Monserrato (CA), Italy

Session
IBD (Posters)

Conference
UEG Week Vienna 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing